Vizimpro 45 mg/1

Vizimpro 45 mg is a medication used to treat certain types of cancer. This oral tablet contains dacomitinib, a targeted therapy designed to inhibit specific cancer cell growth. Learn more about Vizimpro's uses and effects.

Vizimpro 45 mg is primarily used in the treatment of non-small cell lung cancer (NSCLC). It works by targeting and inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. This medication is often prescribed for patients with specific genetic mutations. What is Vizimpro used for? It is used as a targeted therapy to manage certain types of lung cancer.

Common effects of Vizimpro 45 mg may include skin rash, diarrhea, and fatigue. Some users may also experience nausea, decreased appetite, and mouth sores. These effects can vary in severity and may require monitoring by a healthcare professional.

Vizimpro should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions. Patients should be aware of potential side effects and report any severe or persistent symptoms to their healthcare provider.

Vizimpro may interact with certain medications, including those that are metabolized by the liver's CYP enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy and safety of Vizimpro.